Measurement of the Performance and Safety of RTR+Membrane in Guided Tissue Regeneration (GTR) in Dental Surgical Procedures

NCT ID: NCT06467630

Last Updated: 2024-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-09

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to measure in real practice the performance and safety of RTR+Membrane, a synthetic dental membrane for guided tissue regeneration in periodontal or dental implant surgery. The main question it aims to answer is to measure the post-operative wound healing several months after surgery. Participants will be followed after their dental surgery via clinical examination and radiological and photos images.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants are any adult patients with one of the 3 following dental treatments to be done with RTR+Membrane:

* post-extraction socket preservation,
* alveolar ridge augmentation,
* Guided Tissue Regeneration (GTR) during immediate implant placement.

Since it is a real-life evidence study in current practice, patients will be followed at their surgery and their follow-ups. Below are listed visits and type of data collected.

* V1 - Surgery: Demography, Medical history and concomitant treatments, Clinical/technical information (tooth extraction, surgery, membrane and grafting materials use), Clinical Exam, Photography, X-rays or Cone Beam Computed Tomography (CBCT)
* V2 - Early follow-up (including suture removal, if needed): Clinical Exam, Questionnaire, Photography
* V2bis - Early follow-up: Clinical Exam, Photography
* V3 - Late follow-up: Clinical Exam, Photography, X-rays or CBCT, Questionnaire

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Guided Bone Regeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Post-extraction socket preservation group

The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Post-extraction socket preservation (not done concomitantly to implant placement).

Preserving alveolar bone volume after tooth extraction

Intervention Type PROCEDURE

* Visit 1: A periodontal or dental implant surgery is done aiming to preserve alveolar bone volume after extraction
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* V2bis (1 month +/- 1 week) - Early post-surgery follow-up
* Visit 3 (5 months ± 1 month) - Late post-surgery follow-up

Alveolar ridge augmentation group

The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Alveolar ridge augmentation (not done concomitantly to implant placement).

Alveolar crest reconstruction

Intervention Type PROCEDURE

* Visit 1: A periodontal or dental implant surgery is done aiming to alveolar crest reconstruction
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* Visit 3 (5 months ± 1 month) - Late post-surgery follow-up

Guided Tissue Regeneration (GTR) during immediate implant placement group

The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Guided Tissue Regeneration (GTR) during immediate implant placement

Covering bone defects during immediate implant placement.

Intervention Type PROCEDURE

* Visit 1: A periodontal or dental implant surgery is done aiming to cover bone defects during immediate implant placement.
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* Visit 3 (3 months ± 1 month) - Late post-surgery follow-up

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Preserving alveolar bone volume after tooth extraction

* Visit 1: A periodontal or dental implant surgery is done aiming to preserve alveolar bone volume after extraction
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* V2bis (1 month +/- 1 week) - Early post-surgery follow-up
* Visit 3 (5 months ± 1 month) - Late post-surgery follow-up

Intervention Type PROCEDURE

Alveolar crest reconstruction

* Visit 1: A periodontal or dental implant surgery is done aiming to alveolar crest reconstruction
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* Visit 3 (5 months ± 1 month) - Late post-surgery follow-up

Intervention Type PROCEDURE

Covering bone defects during immediate implant placement.

* Visit 1: A periodontal or dental implant surgery is done aiming to cover bone defects during immediate implant placement.
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* Visit 3 (3 months ± 1 month) - Late post-surgery follow-up

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female adult patient
* Patient with one of the 3 following dental treatments to be done with the study device: post-extraction socket preservation, alveolar ridge augmentation, or Guided Tissue Regeneration (GTR) during immediate implant placement.
* Patient affiliated or beneficiary of a social security system.
* Patient has signed his/her informed consent form.

Exclusion Criteria

* Pregnancy or lactation
* Active tissue infection at the implant site
* Several dental treatments done simultaneously in non-contiguous dental zones
* Heavy smoker (\>10 cigarettes / day)
* Patient receiving long-term corticosteroid therapy, anti-rejection drugs, bisphosphonates, head \& neck radiotherapy or chemotherapy
* Patient with chronic infections (such as osteomyelitis) at the surgical site
* Patient with poorly controlled metabolic disorders (such as diabetes, osteomalacia, thyroid disorders)
* Patient with an auto-immune disease
* Patient under tutelage, vulnerable person, person without liberty, or unable to complete questionnaire independently
Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Septodont

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alain Hoornaert, DDS

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Nantes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital University of Nantes

Nantes, , France

Site Status RECRUITING

Private dental practice office of Dr. Alain Hoornaert

Nantes, , France

Site Status RECRUITING

Private dental practice office of Dr. Samer Saloum-Rouxel

Nantes, , France

Site Status NOT_YET_RECRUITING

Private dental practice office of Dr. Xavier Struillou

Nantes, , France

Site Status NOT_YET_RECRUITING

Private dental practice office of Dr. Edouard Lanoiselée

Nozay, , France

Site Status NOT_YET_RECRUITING

Private dental practice office of Dr. Aurélien Fruchet

Olonne-sur-Mer, , France

Site Status NOT_YET_RECRUITING

Private dental practice office of Dr. Hélène Le Hécho

Orée d'Anjou, , France

Site Status RECRUITING

Private dental practice office of Dr. Nicolas Strube

Orvault, , France

Site Status NOT_YET_RECRUITING

Private dental practice office of Dr. Romain Besnier

Orvault, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

CCP from the Sponsor

Role: CONTACT

+33 1 49 76 70 00

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alain Hoornaert, DDS

Role: primary

Alain Hoornaert, DDS

Role: primary

Samer Saloum-Rouxel, DDS

Role: primary

Xavier Struillou, DDS

Role: primary

Edouard Lanoiselée, DDS

Role: primary

Aurélien Fruchet, DDS

Role: primary

Hélène Le Hécho, DDS

Role: primary

Nicolas Strube, DDS

Role: primary

Romain Besnier, DDS

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RTR+ 2023-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.